Brightsurf Science News & Current Events

October 01, 2000
Recovery from spinal injury
Victims of debilitating spinal cord injuries may in the future have greater chances for recovery of some locomotive functions, thanks to pioneering spinal cord research by Texas A&M University neuroscientist James Grau.

Sea may be source of future medicines
A great diversity of actinomycetes bacteria with potential as sources of medical drugs have been found living in marine sponges.

Archaeologists discover ancient untouched tomb in Syria
An ancient, untouched tomb of what may be royalty from one of the world's first city-dwelling civilizations has been discovered in Syria, containing human and animal remains, gold and silver treasures and unbroken artifacts that had not been disturbed for about 4,300 years.

Survey indicates oncologists support for euthanasia and physician-assisted suicide declined dramatically
The largest survey on physician attitudes and practices on euthanasia and physician-assisted suicide, sponsored by the American Society of Clinical Oncology, found that oncologists' support has declined dramatically.

Marshall tests membranes for future space structures
Engineers at Marshall Space Flight Center in Huntsville, Ala., have completed tests on an experimental lightweight, inflatable structure that one day might lead to optical, solar power or propulsion uses in space.

NHLBI launches genomic applications initiative -- $37 million awarded in initial effort
Through its new Programs for Genomic Applications initiative, the NHLBI has issued grants totaling $37 million for human genomic research related to heart, lung, blood, and sleep functions and disorders.

Six universities, INEEL announce collaborative research projects
Thirteen research projects have been selected for initial funding as part of the first joint collaborative effort between the Inland Northwest Research Alliance and DOE's Idaho National Engineering and Environmental Laboratory.

International research group led by UMass scientist sequences genome of ubiquitous microbe
A team of scientists at the University of Massachusetts has completed the genome sequence of Halobacterium species NRC-1, an

Drug shown to preserve ovarian function in mice
Researchers at Memorial Sloan-Kettering Cancer Center, along with colleagues from Massachusetts General Hospital and other institutions, have discovered that

Clotting protein may be link to heart disease
A little known clotting protein called fibrinogen may be the missing link between heart disease risk factors, such as smoking and high cholesterol, and heart attacks, according to a study in today's Circulation: Journal of the American Heart Association.

Study links teen smoking to symptoms of depression
It's commonly thought that teen depression can lead to cigarette smoking, but a new study, published in the October edition of Pediatrics, shows it's the smoking that increases the risk of depression.

The visible humans grow up
The Visible Humans, computer-generated images of a male and a female cadaver, have in many ways revolutionized the way we teach and practice medicine.

Treatment protects mouse ovaries from radiation therapy
A team of researchers from the Massachusetts General Hospital, Memorial Sloan-Kettering Cancer Center, and other research centers has found a molecule that, in animal studies, has blocked the destruction of ovarian egg cells by radiation therapy.

Breast reconstruction during mastectomy boosts well-being most, study finds
Women who have a breast reconstructed after mastectomy gain large improvements in their emotional, social and functional well-being, regardless of the technique or timing they choose, a new study finds.

UCSF finding suggests mechanism of experimental cancer drug, hinting at broader application for the drug, a modified cold virus
UC San Francisco researchers may have discovered why the experimental anti-cancer drug Onyx-015 works more broadly than had been expected, a finding that could solidify and expand use of the drug and which reveals a potential new target for therapy that could prompt the development of other cancer drugs.
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.